TABLE OF CONTENTS
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF EUROPE COCHLEAR IMPLANTS MARKET
1.4 CURRENCY AND PRICING
1.5 LIMITATIONS
1.6 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 MARKETS COVERED
2.2 GEOGRAPHICAL SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 DBMR TRIPOD DATA VALIDATION MODEL
2.5 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.6 DBMR MARKET POSITION GRID
2.7 VENDOR SHARE ANALYSIS
2.8 MULTIVARIATE MODELING
2.9 PRODUCTS LIFELINE CURVE
2.10 SECONDARY SOURCES
2.11 ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
5 MARKET OVERVIEW
5.1 DRIVERS
5.1.1 RISING AWARENESS TOWARDS HEARING AIDS
5.1.2 TECHNOLOGICAL ADVANCEMENTS IN MAKING EFFICIENT DEVICES WITH INCREASED BATTERY LIFE
5.1.3 ADEQUATE REIMBURSEMENT SCENARIO
5.1.4 INCREASING NUMBER OF CASES OF HEARING LOSS
5.1.5 GROWING NUMBER OF HEARING AID CLINICS
5.2 RESTRAINTS
5.2.1 HIGH COST OF IMPLANTS
5.2.2 DEARTH OF SKILLED PROFESSIONAL
5.2.3 POST IMPLANTS COMPLICATIONS INCLUDING FACIAL PARALYSIS, POST-OPERATIVE SENSE OF IMBALANCE AND DAMAGE TO NERVES
?
5.3 OPPORTUNITIES
5.3.1 INTRODUCTION OF INNOVATIVE PRODUCT IN THE MARKET
5.3.2 INCREASING GOVERNMENT AND NON-GOVERNMENT INITIATIVE.
5.3.3 IMPROVED OUTCOMES LEADS TO EXPANSION OF INDICATION
5.3.4 UNMET AND UNADDRESSABLE CLINICAL NEED FOR COCHLEAR IMPLANT ACROSS THE GLOBE
5.4 CHALLENGES
5.4.1 MANUAL AND LABOR INTENSIVE PRODUCTION
5.4.2 NEED FOR LONG-TERM IMPLANTABLE AND RECHARGEABLE BATTERIES, CONNECTORS AND SAFETY
6 EUROPE COCHLEAR IMPLANTS MARKET, BY TYPE
6.1 OVERVIEW
6.2 PRODUCT
6.3 ACCESSORIES
6.4 SOFTWARE
7 EUROPE COCHLEAR IMPLANTS MARKET, BY TECHNOLOGY
7.1 OVERVIEW
7.2 ELECTRO-ACOUSTIC STIMULATION (EAS)
7.3 ACOUSTIC AMPLIFICATION TECHNOLOGY
7.4 ELECTRO-STIMULATION TECHNOLOGY
8 EUROPE COCHLEAR IMPLANTS MARKET, BY AGE
8.1 OVERVIEW
8.2 ADULTS
8.2.1 BILATERAL IMPLANTATION
8.2.2 UNILATERAL IMPLANTATION
8.3 PEDIATRICS
8.3.1 BILATERAL IMPLANTATION
8.3.2 UNILATERAL IMPLANTATION
9 EUROPE COCHLEAR IMPLANTS MARKET, BY END USER
9.1 OVERVIEW
9.2 HOSPITAL
9.3 ENT CLINICS
9.4 AMBULATORY SURGERY CENTER
10 EUROPE COCHLEAR IMPLANTS MARKET, BY DISTRIBUTION CHANNEL
10.1 OVERVIEW
10.2 DIRECT
10.3 RETAIL
11 EUROPE COCHLEAR IMPLANTS MARKET, BY GEOGRAPHY
11.1 EUROPE
11.1.1 GERMANY
11.1.2 FRANCE
11.1.3 U.K.
11.1.4 ITALY
11.1.5 SPAIN
11.1.6 SWITZERLAND
11.1.7 NETHERLANDS
11.1.8 BELGIUM
11.1.9 TURKEY
11.1.10 RUSSIA
11.1.11 REST OF EUROPE
12 EUROPE COCHLEAR IMPLANTS MARKET, COMPANY LANDSCAPE
12.1 COMPANY SHARE ANALYSIS: EUROPE
13 COMPANY PROFILES
13.1 COCHLEAR LTD.
13.1.1 COMPANY SNAPSHOT
13.1.2 REVENUE ANALYSIS
13.1.3 COMPANY SHARE ANALYSIS
13.1.4 PRODUCT PORTFOLIO
13.1.5 RECENT DEVELOPMENTS
13.2 ADVANCED BIONICS AG (A SUBSIDIARY OF SONOVA)
13.2.1 COMPANY SNAPSHOT
13.2.2 REVENUE ANALYSIS
13.2.3 COMPANY SHARE ANALYSIS
13.2.4 SOLUTION PORTFOLIO
13.2.5 RECENT DEVELOPMENT
13.3 MED-EL MEDICAL ELECTRONICS
13.3.1 COMPANY SNAPSHOT
13.3.2 COMPANY SHARE ANALYSIS
13.3.3 PRODUCT PORTFOLIO
13.3.4 RECENT DEVELOPMENTS
13.4 MEDTRONIC
13.4.1 COMPANY SNAPSHOT
13.4.2 REVENUE ANALYSIS
13.4.3 PRODUCT PORTFOLIO
13.4.4 RECENT DEVELOPMENT
13.5 NUROTRON BIOTECHNOLOGY CO. LTD.
13.5.1 COMPANY SNAPSHOT
13.5.2 PRODUCT PORTFOLIO
13.5.3 RECENT DEVELOPMENTS
13.6 OTICON A/S
13.6.1 COMPANY SNAPSHOT
13.6.2 REVENUE ANALYSIS
13.6.3 PRODUCT PORTFOLIO
13.6.4 RECENT DEVELOPMENTS
13.7 WIDEX A/S
13.7.1 COMPANY SNAPSHOT
13.7.2 PRODUCT PORTFOLIO
13.7.3 RECENT DEVELOPMENT
14 QUESTIONNAIRE
15 RELATED REPORTS